Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of HBOC-201 in Trauma Subjects
NCT00301483Phase 2Unknown
- Sponsor
- Biopure
- Start
- Jul 2004
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of hemoglobin glutamer-250 in hypoperfusion, psychological trauma, sponsored by Biopure. Status: unknown.
02
Drugs
hemoglobin glutamer-250
03
Conditions
hypoperfusionpsychological trauma
Beyond the preview
Go deeper on NCT00301483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00301483.